InvestorsHub Logo
Followers 2662
Posts 8617
Boards Moderated 0
Alias Born 11/08/2012

Re: vegasvic post# 33161

Monday, 12/31/2012 12:24:31 PM

Monday, December 31, 2012 12:24:31 PM

Post# of 130513
barber shop..US GOV’T., AMBS & BANYAN BIOMARKERS.. Dr. Zimmerman from Bayer on AMBS: "I have been involved with Amarantus formally and informally for the past three years supporting the founders as they work tirelessly to advance MANF to a stage where it has real commercial potential," said Robert J. Zimmerman, SD. "While that effort has been centered on Parkinson's disease, I believe additional opportunities exist to diversify this therapeutic candidate. Ischemia/reperfusion, cardiovascular disease, stroke, traumatic brain injury, diabetes and potentially other disease conditions appear to be impacted by MANF based upon preclinical studies and the literature."

TBI IMO is the real deal for AMBS.